Balchem (BCPC) Reaches New 1-Year High and Low at $96.61

Balchem Co. (NASDAQ:BCPC) shares reached a new 52-week high and low on Wednesday . The stock traded as low as $96.61 and last traded at $96.33, with a volume of 2460 shares traded. The stock had previously closed at $95.08.

Several research analysts have recently weighed in on the stock. BidaskClub cut shares of Balchem from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 12th. Vertical Group cut shares of Balchem from a “buy” rating to a “hold” rating in a report on Monday, May 7th. They noted that the move was a valuation call. Finally, Pivotal Research raised shares of Balchem from a “sell” rating to a “hold” rating and set a $85.00 price target on the stock in a report on Monday, May 7th.

Get Balchem alerts:

The firm has a market capitalization of $3.07 billion, a price-to-earnings ratio of 35.23 and a beta of 0.94. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 2.16.

Balchem (NASDAQ:BCPC) last released its quarterly earnings results on Friday, May 4th. The basic materials company reported $0.76 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.06. The firm had revenue of $161.41 million for the quarter. Balchem had a net margin of 15.18% and a return on equity of 14.50%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. SeaCrest Wealth Management LLC bought a new position in Balchem in the fourth quarter valued at $113,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Balchem by 57.1% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,829 shares of the basic materials company’s stock valued at $150,000 after acquiring an additional 665 shares during the last quarter. Eagle Boston Investment Management Inc. bought a new position in Balchem in the first quarter valued at $211,000. SG Americas Securities LLC bought a new position in Balchem in the first quarter valued at $213,000. Finally, Xact Kapitalforvaltning AB bought a new position in Balchem in the fourth quarter valued at $286,000. 87.38% of the stock is currently owned by institutional investors and hedge funds.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.